Explore our latest innovations and publications and discover how we leverage human iPSC technology to catalyze drug discovery.
Scientific poster: Evaluation of human iPSC derived triculture as in vitro model for neuroinflammation
Scientific poster: Development of a robust and scalable iPSC platform for predictions of efficacy and in vivo toxicity of RNA therapeutics in the drug discovery pipeline
Scientific poster: Development of a robust and scalable hiPSC platform for the identification of efficacious and less toxic ASOs
Research highlights: Targeted Protein Degradation in Tauopathies
Case Study: Development of a human iPSC-derived ALS model
The status of drug discovery and development for Parkinson's disease